Lilly COVID-19 Neutralizing Antibody Combo’s Reduced Infusion Time Offers Advantages For Providers

 
• By Joseph Haas
  
Coronavirus
Lilly is testing the antibody combo against all variants seen in the US
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip